Version 5.4
Bos taurus Gene: PI16
Summary
InnateDB Gene IDBG-630281.3
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol PI16
Gene Name Peptidase inhibitor 16
Synonyms PI-16
Species Bos taurus
Ensembl Gene ENSBTAG00000002092
Encoded Proteins
IDBP-681727
Peptidase inhibitor 16
IDBP-681729
Peptidase inhibitor 16
Protein Structure
Useful resources Stemformatics EHFPI ImmGen
Entrez Gene
Summary This gene does not have any Entrez summary - the following is the summary from its human ortholog ENSG00000164530:
Gene Information
Type Protein coding
Genomic Location Chromosome 23:10836790-10848749
Strand Forward strand
Band
Transcripts
ENSBTAT00000002703 ENSBTAP00000002703
ENSBTAT00000047585 ENSBTAP00000044778
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
Gene Ontology

Molecular Function
Accession GO Term
GO:0030414 peptidase inhibitor activity
Biological Process
GO:0010466 negative regulation of peptidase activity
GO:0061052 negative regulation of cell growth involved in cardiac muscle cell development
Cellular Component
GO:0005576 extracellular region
GO:0005615 extracellular space
GO:0016020 membrane
GO:0016021 integral component of membrane
GO:0070062 extracellular vesicular exosome
Orthologs
Species
Homo sapiens
Mus musculus
Gene ID
Gene Order
ENSG00000164530
View Gene Order
ENSMUSG00000024011
View Gene Order
Cross-References
SwissProt Q58D34
TrEMBL
UniProt Splice Variant
Entrez Gene 507058
UniGene Bt.4912
RefSeq NM_001024487 XM_005223311
HUGO
OMIM
CCDS
HPRD
IMGT
EMBL BC119955 BT021763
GenPept AAI19956 AAX46610
RNA Seq Atlas 507058

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca